Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction
NCT ID: NCT05658835
Last Updated: 2024-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
311 participants
OBSERVATIONAL
2023-02-08
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
NCT03268668
Multimodal Investigation of Intracranial Clot Environment
NCT04421326
Precision Medicine in Stroke
NCT05815836
Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)
NCT06451887
Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort
NCT01363856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient suffering from ischemic stroke
Thrombi and blood analyses
Thrombi and blood will be collected during thrombectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thrombi and blood analyses
Thrombi and blood will be collected during thrombectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a cerebral infarction documented by brain imaging who received endovascular treatment by mechanical thrombectomy;
* Patient for whom it was possible to collect cerebral thrombus for LC-MS analysis during mechanical thrombectomy:
* Patient who was informed of the study and formulated a non-opposition to participation. If not, patient for whom a relative was informed and formulated a non-opposition.
Exclusion Criteria
* Protected persons (articles L1121-5, L1121-6 and L121-8 of the Public Health Code): pregnant or breast-feeding women, persons deprived of liberty, under guardianship or curatorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François Crémieux
Role: STUDY_DIRECTOR
AP-HM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Martinique
Fort-de-France, , France
Stroke Center
Marseille, , France
CHU Guadeloupe
Pointe à Pitre, , France
CHU La Réunion
Saint-Pierre, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Quentin Bourgeois
Role: primary
Anne Landais
Role: primary
Mirebeau Gabriel
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB
Identifier Type: OTHER
Identifier Source: secondary_id
RCAPHM22_0231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.